XML 17 R6.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Statements of Cash Flows - USD ($)
 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Cash flows from operating activities:    
Net loss $ (1,184,497) $ (1,130,173)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 8,160 8,640
Bad debt expense 758 16,123
Amortization of deferred financing costs 2,124 10,761
Amortization of beneficial conversion option 0 133,549
Stock issued for services 62,500  
Stock options compensation 113,589 421,000
Note conversion warrant expense 137,970 0
Changes in operating assets and liabilities:    
Accounts receivable (112,814) (166,616)
Prepaid expenses and other current assets (125,544) (7,664)
Accounts payable and accrued expenses (116,262) 185,141
Other long-term liabilities - related parties (12,852) 77,377
Deferred interest expense 23,226 20,802
Deferred revenues (46,007) 19,949
Total adjustments (65,152) 719,062
Net cash used in operating activities (1,249,649) (411,111)
Cash flows from investing activities:    
Purchases of property and equipment (6,867) (3,888)
Net cash used in investing activities (6,867) (3,888)
Cash flows from financing activities:    
Sale of Common Stock 559,285 0
Exercise of stock options 3,500 0
Proceeds from notes payable - related parties 0 582,000
Repayment of notes payable (180,000) (155,813)
Repayment of notes payable - related parties (83,834) (23,248)
Net cash provided by financing activities 298,951 402,939
Net increase (decrease) in cash (957,565) (12,060)
Cash - beginning of period 1,117,118 184,081
Cash - end of period 159,553 172,021
Supplemental disclosure of cash flow information:    
Cash paid during the period for interest and taxes 35,808 18,851
Supplemental disclosure of non-cash financing activities:    
Accrued interest notes payable converted to equity 35,038 0
Discount on notes payable - related parties for beneficial conversion feature 0 170,092
Notes payable conversion warrant expense 113,762 0
Notes payable conversion underwriting warrant expense 24,207 0
Notes payable converted to equity $ 135,000 $ 0